SOMNUM (SOMNUM)

Honeynaps Co., Ltd. · K253390 · 2026-06-27

SOMNUM (SOMNUM) is an AI-enabled medical device from Honeynaps Co., Ltd., listed by FDA (510(k), K253390) with a decision date of 2026-06-27. Review panel: Neurology.

FDA submission numberK253390
Pathway510(k)
CompanyHoneynaps Co., Ltd.
Review panel (specialty)Neurology
FDA decision date2026-06-27
DecisionSubstantially Equivalent
Product codeOLZ
ClassificationAutomatic Event Detection Software For Polysomnograph With Electroencephalograph
Device class2
Regulation number882.1400
Review time (calendar days)270
Applicant countryKR

Official FDA database record · FDA AI-enabled device list

All Neurology AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.